We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$59.2B
AUM Growth
-$597M
Cap. Flow
+$16.6M
Cap. Flow %
0.03%
Top 10 Hldgs %
14.76%
Holding
3,335
New
150
Increased
1,066
Reduced
1,517
Closed
312

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 14.67%
3 Healthcare 12.58%
4 Consumer Discretionary 10.4%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUTU icon
2901
Futu Holdings
FUTU
$14.8B
$23K ﹤0.01%
256
SYRE icon
2902
Spyre Therapeutics
SYRE
$8.93B
$23K ﹤0.01%
120
-841
-88% -$147K
LEJU
2903
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$23K ﹤0.01%
2,115
CRIS icon
2904
Curis
CRIS
$5.81M
$22K ﹤0.01%
+7
New +$21.9K
VTGN icon
2905
VistaGen Therapeutics
VTGN
$11.4M
$22K ﹤0.01%
+277
New +$24.1K
NEXA icon
2906
Nexa Resources
NEXA
$1.99B
$20K ﹤0.01%
2,778
ORIC icon
2907
Oric Pharmaceuticals
ORIC
$1.46B
$20K ﹤0.01%
+1,004
New +$20.4K
GTT
2908
DELISTED
GTT Communications, Inc.
GTT
$20K ﹤0.01%
107,087
-197,079
-65% -$465K
ATHX
2909
DELISTED
Athersys, Inc. Common Stock
ATHX
$19K ﹤0.01%
575
CUE icon
2910
Cue Biopharma
CUE
$110M
$17K ﹤0.01%
40
-2,045
-98% -$713K
MSTR icon
2911
Strategy Inc
MSTR
$38.7B
$17K ﹤0.01%
310
-4,910
-94% -$315K
OTTR icon
2912
Otter Tail
OTTR
$3.88B
$17K ﹤0.01%
309
-19,343
-98% -$1.03M
VIVS
2913
VivoSim Labs
VIVS
$1.3M
$17K ﹤0.01%
210
YRD
2914
Yiren Digital
YRD
$109M
$16K ﹤0.01%
+5,297
New +$20.9K
DNTH icon
2915
Dianthus Therapeutics
DNTH
$6.22B
$15K ﹤0.01%
134
-259
-66% -$30.2K
KPTI icon
2916
Karyopharm Therapeutics
KPTI
$45.8M
$14K ﹤0.01%
167
-3,344
-95% -$347K
OPI
2917
DELISTED
Office Properties Income Trust
OPI
$14K ﹤0.01%
555
-119,358
-100% -$3.25M
RFL icon
2918
Rafael Holdings
RFL
$103M
$14K ﹤0.01%
+473
New +$21.7K
JNCE
2919
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$14K ﹤0.01%
2,017
CPIX icon
2920
Cumberland Pharmaceuticals
CPIX
$122M
$13K ﹤0.01%
5,198
GFL icon
2921
GFL Environmental
GFL
$15B
$13K ﹤0.01%
353
-101,143
-100% -$3.49M
RGS icon
2922
Regis Corp
RGS
$71.5M
$13K ﹤0.01%
+200
New +$26.3K
XBIT icon
2923
XBiotech
XBIT
$69.5M
$13K ﹤0.01%
1,023
BNT
2924
Brookfield Wealth Solutions
BNT
$12.6B
$10K ﹤0.01%
285
-4,754
-94% -$179K
ASRT
2925
DELISTED
Assertio
ASRT
$8K ﹤0.01%
650
-2,186
-77% -$37.4K

Similar funds

Russell Investments Group's Q3 2021 Portfolio in Review

As of Q3 2021, Russell Investments Group held 3,335 positions worth $59.2B, down 1% from $59.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Russell Investments Group's Q3 2021 filing shows 150 new, 1,066 increased, 1,517 reduced and 312 closed positions. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 2,808,752 shares worth $170M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $274M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Russell Investments Group's largest Q3 2021 buy was iShares MSCI Emerging Markets ex China ETF: 2,808,752 shares worth $170M.
  • Russell Investments Group added most to NiSource Inc. Series A Corporate Units in Q3 2021, an estimated $134M increase.
  • Russell Investments Group's biggest Q3 2021 reduction was Equity Residential, cutting an estimated $72.5M.
  • Russell Investments Group fully exited Vanguard FTSE Emerging Markets ETF in Q3 2021, selling an estimated $274M.
  • Russell Investments Group's ten largest holdings make up 15% of its $59.2B portfolio in Q3 2021.
  • Russell Investments Group opened 150 new positions and closed 312 in Q3 2021.
  • Russell Investments Group's portfolio value fell 1% quarter-over-quarter to $59.2B.

Based on Russell Investments Group's 13F filing for Q3 2021, filed 8 Nov 2021.